TCL Archive In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million August 19, 1983
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program. May 21, 2004
TCL Archive Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals September 7, 1979
